Testosterone Drugs – Increased Risk of Blood Clots, Heart Attack, & Stroke
Recent studies have shown that dangerous blood clots can occur as early as one month and up to the first 90 days after starting testosterone therapy. The risk of heart attack for men over 65 has nearly doubled. A risk for serious or fatal complications for men under 65 years of age with pre-existing heart disease has nearly tripled. The risk to men with unknown inherited clotting disorders is higher for developing clots. These cardiovascular risks are generally not set forth in the product labels.
Testosterone therapy was initially approved by the FDA to assist with treatment of abnormally low testosterone levels. However, some of the manufacturers of these products are promoting their use for conditions not necessarily related to low testosterone levels, such as energy loss, mood changes, and reduced sex drive among others. These conditions may not be related to low testosterone, but simply the aging process or improper diet and exercise. Because of these aggressive marketing strategies, the estimated sales of testosterone drugs are projected to reach $5 billion by 2017.
The Pharmaceutical Litigation Department at Schlichter, Bogard & Denton, LLP represent clients nationwide who have suffered serious and fatal injuries as a result of dangerous pharmaceutical medications.